Clinical Trial Update: Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase I trial evaluating the safety, tolerability, anti-tumor activity, and pharmacokinetics of Foxy-5 in metastatic breast cancer, colorectal cancer, and pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Prostate Cancer

Drugs mentioned

• Foxy-5

Snippet

Sponsor: WntResearch AB | Conditions: Metastatic Breast Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED